DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1166795
Title:
CD8 T-cell Infiltration as a Predictor of Renal Cancer Progression After Surgery
Descriptive Note:
[Technical Report, Annual Report]
Corporate Author:
EMORY UNIV ATLANTA GA
Report Date:
2021-10-01
Pagination or Media Count:
16
Abstract:
Kidney cancer patients with AJCCTNM Stage III disease represent a significant challenge in selecting the care that should be received after surgery. According to 2019 NCCN guidelines, the decision is whether these patients should either receive sunitinib, enter a clinical trial, or be placed on surveillance. Potentially, this may represent overtreatment or oversurveillance for some patients who are cured, and undertreatment for others. Currently, there are not good indicators to guide which path patients should be follow, thus, appropriate biomarkers are needed to improve prognostication for patients with this stage of disease.
Distribution Statement:
[A, Approved For Public Release]